Puma Biotechnology | PBYI - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Esperion Therapeutics USD 68.41M 3.34M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Gilead Sciences USD 645M 70M 2026-03
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Incyte USD 228.62M 1.41B 2026-03
MacroGenics USD 4.29M 500K 2026-03
Moderna USD 161M 156M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Takeda JPY 491.34B 23.75B 2026-03
TG Therapeutics USD 148.84M 41.34M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03